What Is Uterine (or Endometrial) Cancer?

Types of Uterine Cancer
- Endometrial Cancer This type of uterine cancer develops in the lining of the uterus, which is also known as the endometrium. Approximately 95 percent of uterine cancers are endometrial, which is why the terms “endometrial cancer” and “uterine cancer” are often used interchangeably.
- Uterine Sarcoma This type of uterine cancer originates in the muscle wall of the uterus. It is relatively rare.
Signs and Symptoms of Endometrial Cancer
Endometrial cancer can cause symptoms in both the early and more advanced stages. Roughly 90 percent of patients diagnosed with endometrial cancer report postmenopausal vaginal bleeding, bleeding between periods, or very heavy bleeding during their menstrual cycle.
- Abnormal vaginal discharge (even with no traces of blood)
- Pelvic pain
- Pain during intercourse
- Difficulty urinating
- A mass in the pelvic area
- Unexpected weight loss

Causes and Risk Factors of Endometrial Cancer
- Age (older than 50)
- Obesity
- Estrogen-only hormone replacement therapy after menopause
- A history of irregular menstrual periods
- Difficulty getting pregnant
- Use of tamoxifen (Nolvadex) to treat breast cancer
- A family history of uterine cancer, colon cancer, or ovarian cancer
- Beginning menstruation before age 12 and menopause later than average
- History of infertility or never having been pregnant
- Endometrial hyperplasia, an abnormal overgrowth of cells in the lining of the uterus
- Radiation therapy to the pelvic region
- Diabetes
- BRCA mutations or a PTEN mutation
How Is Endometrial Cancer Diagnosed?
- Pelvic Exam During a pelvic exam, your doctor will insert two fingers into the vagina while pressing the other hand down on the abdomen to feel for abnormalities in the uterus and the ovaries. A speculum is inserted into the vagina to visually inspect the area.
- Transvaginal Ultrasound In this exam, a wandlike device known as a transducer is inserted into the vagina to create an ultrasound video image of the thickness of the uterine lining and determine if there are irregularities.
- Hysteroscopy During this test, a lighted tube, or hysteroscope, is inserted into the vagina and through the cervix to gain access to and examine the uterus and uterine lining.
- Endometrial Biopsy Thin suction tubing is used to remove tissue from the uterine lining to be examined and analyzed by a laboratory.
- Dilation and Curettage If an endometrial biopsy is inconclusive, it may be necessary to do a more extensive procedure called dilation and curettage, or D&C. The cervix is dilated for better access to the uterus and the endometrial lining is scraped to get additional tissue for testing.
Stages of Uterine Cancer
- Stage 1 The cancer has not spread beyond the uterus.
- Stage 2 The cancer has spread from the uterus to the cervix.
- Stage 3 The cancer has spread from the uterus to the vagina, ovaries, and lymph nodes.
- Stage 4 The cancer has spread to the bladder, rectum, lungs, or bones.
Treatment Options for Endometrial Cancer
Endometrial cancer is treated by one or a combination of treatments. Ultimately, treatment for uterine cancer depends on the type of cancer and how extensive it is, as well as whether it is localized or has spread (metastasized). Other factors include overall health, age, and personal preferences, such as whether it is important to preserve fertility.
Surgery
Hormone Therapy
Hormone therapy blocks or changes the effects of hormones that contribute to cancer growth. It’s sometimes used in patients who want to preserve the uterus and their fertility. It’s also often used to treat stage 3 or 4 cancer or cancer that has recurred after treatment.
- Progestins, which are the primary hormone treatment prescribed
- Aromatase inhibitors (AIs)
- Tamoxifen
- Fulvestrant
- CDK 4/6 inhibitors
Chemotherapy
Chemotherapy is a type of cancer treatment that uses powerful medicine to kill cancer cells. It’s an effective way to treat cancer, but it also can cause unpleasant side effects such as nausea, fatigue, hair loss, nerve damage, and a loss of appetite. It can be used alone or in combination with other treatments, like surgery and radiation, to improve the patient’s chance for survival.
- bevacizumab (Avastin)
- carboplatin
- cisplatin
- docetaxel (Taxotere)
- doxorubicin (Adriamycin) or liposomal doxorubicin (Doxil)
- gemcitabine
- paclitaxel (Taxol)
Radiation Therapy
- Internal radiation therapy, which is when radioactive materials are placed inside the body. It’s also known as brachytherapy.
- External beam radiation therapy, which is performed with a machine that focuses radiation beams at the tumor.
Targeted Therapy
Targeted drugs include:
- bevacizumab (Avastin), Trastuzamab (Herceptin)
- cabozantinib (Cabometx)
- entrectinib (Rozlytrek)
- everolimus (Afinitor)
- fam-trastuzumab deruxtecan-nxki (Enhertu)
- larotrectinib (Vitrakyi)
- lenvatinib (Lenvima)
- temsirolimus (Torisel)
Immunotherapy
Prevention of Uterine Cancer
- Maintain a healthy weight. Women who are overweight are more likely to get endometrial cancer.
- Exercise regularly. Higher levels of physical activity have been linked to a lower risk of endometrial cancer. Regular exercise can also help you maintain a healthy weight and lower the risk of high blood pressure and diabetes, both of which are risk factors for endometrial cancer.
- Use hormonal contraceptives. Birth control pills, patches, rings, implants, or an IUD may reduce your endometrial cancer risk.
Lifestyle Changes
Uterine Cancer Prognosis
Every patient with uterine cancer is different, and so are their health outcomes. When diagnosed early, patients with uterine cancer have a very good prognosis.
Complications of Uterine Cancer
- Anemia due to blood loss before diagnosis
- Perforation (hole) of the uterus, which may occur during a dilation and curettage (D&C) or endometrial biopsy
- Nausea or vomiting from chemotherapy
- Increased risk of infection from surgery, radiation, and chemotherapy
Research and Statistics
Disparities and Inequities in Uterine Cancer
The Takeaway
- Uterine cancer, also called endometrial cancer, is the most common gynecological cancer in the United States. It is diagnosed most frequently in postmenopausal women.
- Early diagnosis and treatment of uterine cancer can lead to a very good prognosis. Surgery is the main treatment option, but others include hormone therapy, chemotherapy, radiation, targeted drugs, and immunotherapy.
- If you experience postmenopausal bleeding, difficulty urinating, or pelvic pain, seek medical attention right away, as these can be symptoms of uterine cancer.
Common Questions & Answers
Resources We Trust
- Cleveland Clinic: Uterine Cancer (Endometrial Cancer)
- Mayo Clinic: Cancer Diagnosis: 11 Tips for Coping
- Ovarian Cancer Research Alliance: Support Resources
- National Cancer Institute: Surgery for Endometrial Cancer
- American Cancer Society: Preserving Your Fertility When You Have Cancer
- Uterine Cancer Statistics. Centers for Disease Control and Prevention. September 9, 2024.
- Uterine Cancer (Endometrial Cancer). Cleveland Clinic. March 21, 2023.
- Different Types of Uterine Cancer: Risk Factors, Diagnosis, and Treatment. University of Kansas Cancer Center.
- Uterine (Endometrial) Cancer Signs & Symptoms. Memorial Sloan Kettering Cancer Center.
- Uterine (Endometrial) Cancer Risk Factors & Prevention. Memorial Sloan Kettering Cancer Center.
- Tests for Endometrial Cancer. American Cancer Society. February 28, 2025.
- Stages of Uterine (Endometrial) Cancer. Memorial Sloan Kettering Cancer Center.
- Hysterectomy. Cleveland Clinic. May 31, 2024.
- Hormone Therapy for Endometrial Cancer. American Cancer Society. February 28, 2025.
- Chemo for Endometrial Cancer. American Cancer Society. February 28, 2025.
- Radiation Therapy for Endometrial Cancer. NYU Langone Health Perlmutter Cancer Center.
- Radiation for Endometrial Cancer. American Cancer Society. February 28, 2025.
- Targeted Therapy for Endometrial Cancer. American Cancer Society. February 28, 2025.
- Immunotherapy for Endometrial Cancer. American Cancer Society. February 28, 2025.
- Mirza MR et al. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer. The New England Journal of Medicine. June 8, 2023.
- Endometrial Cancer Prevention. National Cancer Institute. August 21, 2023.
- Lifestyle Changes Women Should Consider to Prevent Cancer. Rogel Cancer Center University of Michigan Health.
- Uterine Cancer Outcomes. Emory Winship Cancer Institute.
- Endometrial Cancer. MedlinePlus. March 31, 2024.
- Key Statistics for Endometrial Cancer. American Cancer Society. February 28, 2025.
- Piersol W. Endometrial Cancer: New Insights into a Deadly Disparity. Memorial Sloan Kettering Cancer Center. December 19, 2023.
- Weigelt et al. Molecular Characterization of Endometrial Carcinomas in Black and White Patients Reveals Disparate Drivers With Therapeutic Implications. Cancer Discovery. November 1, 2023.

Nimit Sudan, MD
Medical Reviewer
Nimit Sudan, MD, is a hematologist and medical oncologist with UCLA. He is an assistant clinical professor at UCLA and serves as a lead physician at the Encino community practice. He has a special interest in integrative medicine and oncology.
Dr. Sudan provides comprehensive care for adult patients with all types of hematologic and oncologic conditions. His mission is to treat every patient with the utmost compassion and care, and to develop a strong doctor-patient relationship. He is passionate about patient and family education, and educating larger communities on cancer awareness and prevention. He also has a special interest in integrative medicine, and is certified in acupuncture.
Sudan is from the Midwest, and received both his medical degree and bachelor's degree from Wayne State University in Detroit, Michigan. He completed his internal medicine residency at the Cleveland Clinic Foundation, and his hematology/oncology fellowship at Western Pennsylvania Hospital in Pittsburgh.

Melba Newsome
Author
Melba Newsome is a veteran freelance journalist with more than 20 years experience reporting on news and general interest topics. She began her career covering what she calls the “freak beat” — writing dramatic narratives about everything from serial-killer groupies to women in harems — for women’s magazines such as Marie Claire, Good Housekeeping, Cosmopolitan, Woman’s Day, and Redbook.
In the past decade, her reporting has focused primarily on education and health, with a concentration on disparities and rural health. A feature in O, The Oprah Magazine about genetic testing earned her the June Roth Award for Medical Journalism. Melba received a Reynolds Institute fellowship and an EWA Reporting fellowship. Thanks to a Crisis Reporting grant from the Pulitzer Center, she has reported extensively on the physiological, emotional, and societal impact of the novel coronavirus.
Melba grew up in the Arkansas Delta and now lives in Charlotte, North Carolina. When there isn’t a pandemic, she enjoys travel and the arts — she’s seen Hamilton six times and traveled to six of the seven continents.